Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ischemic Heart Disease

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 202 articles: HTML format Text format

Single Articles

June 2018
1. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
   Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.
   N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMc1806491.
   PubMed     Text format    
   
   
   
2. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
   Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
   N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMoa1800389.
   PubMed     Text format     Abstract available
   
   
   
3. ARBOINE L, Palacios JM
   Left Main Coronary Artery Aneurysm.
   N Engl J Med. 2018;378:e32.
   PubMed     Text format    
   
   
   May 2018
4. SHAPIRA OM
   Radial Artery as the Preferred Second Conduit for Coronary Bypass.
   N Engl J Med. 2018;378:2134-2135.
   PubMed     Text format    
   
   
   April 2018
5. GAUDINO M, Benedetto U, Fremes S, Biondi-Zoccai G, et al
   Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery.
   N Engl J Med. 2018 Apr 30. doi: 10.1056/NEJMoa1716026.
   PubMed     Text format     Abstract available
   
   
   
6. CAMPBELL BCV, Mitchell PJ, Churilov L, Yassi N, et al
   Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
   N Engl J Med. 2018;378:1573-1582.
   PubMed     Text format     Abstract available
   
   
   
7. BAIRD AE
   Paving the Way for Improved Treatment of Acute Stroke with Tenecteplase.
   N Engl J Med. 2018;378:1635-1636.
   PubMed     Text format    
   
   
   
8. ZHAO YT, Huang YS
   ECG Pattern Associated with Left Anterior Descending Coronary Artery Occlusion.
   N Engl J Med. 2018;378:e22.
   PubMed     Text format    
   
   
   
9. AMELOOT K, Daemen J, Van Mieghem N
   PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
   N Engl J Med. 2018;378:1360-1.
   PubMed     Text format    
   
   
   
10. PAPPALARDO F, Bertoldi L
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360.
    PubMed     Text format    
    
    
    
11. PASCERI V, Pelliccia F, Speciale G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359-60.
    PubMed     Text format    
    
    
    
12. FERREIRA RM, Salis LHA, e Silva NAS
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359.
    PubMed     Text format    
    
    
    
13. FLEISSNER F, Haverich A, Warnecke G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-9.
    PubMed     Text format    
    
    
    
14. SHARMA S, Lardizabal J
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358.
    PubMed     Text format    
    
    
    
15. 
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-1361.
    PubMed     Text format    
    
    
    March 2018
16. LOSCALZO J, Roy N, Shah RV, Tsai JN, et al
    Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure.
    N Engl J Med. 2018;378:1043-1053.
    PubMed     Text format    
    
    
    
17. WHITE WB, Saag KG, Becker MA, Borer JS, et al
    Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
    N Engl J Med. 2018 Mar 12. doi: 10.1056/NEJMoa1710895.
    PubMed     Text format     Abstract available
    
    
    
18. LEE F, Maggiore P, Chung K
    Self-Management of an Inferior ST-Segment Elevation Myocardial Infarction.
    N Engl J Med. 2018;378:960-962.
    PubMed     Text format    
    
    
    February 2018
19. 
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2018;378:782.
    PubMed     Text format    
    
    
    January 2018
20. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    PubMed     Text format    
    
    
    
21. KWONG JC, Schwartz KL, Campitelli MA, Chung H, et al
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:345-353.
    PubMed     Text format     Abstract available
    
    
    
22. CAHILL TJ, Wijesurendra RS, Casadei B
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    PubMed     Text format    
    
    
    
23. HELFT G, Le Feuvre C, Zaman A
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    PubMed     Text format    
    
    
    
24. JEONG YH, Bae JS, Gurbel PA
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:396.
    PubMed     Text format    
    
    
    
25. AJANI AE
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-6.
    PubMed     Text format    
    
    
    
26. 
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-398.
    PubMed     Text format    
    
    
    
27. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    PubMed     Text format    
    
    
    
28. WEBSTER MWI, Stables RH
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    PubMed     Text format    
    
    
    
29. SHAH R
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    PubMed     Text format    
    
    
    
30. VIJ A, Kodumuri V
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    PubMed     Text format    
    
    
    
31. BULLUCK H
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    PubMed     Text format    
    
    
    
32. 
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298-301.
    PubMed     Text format    
    
    
    
33. STONE GW
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:300-1.
    PubMed     Text format    
    
    
    
34. 
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-202.
    PubMed     Text format    
    
    
    
35. LELLOUCHE F, Simon M, L'Her E
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:201.
    PubMed     Text format    
    
    
    
36. SAMADANI U, Affana CK
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-1.
    PubMed     Text format    
    
    
    
37. ROSENBAUM L
    Swallowing a Spy - The Potential Uses of Digital Adherence Monitoring.
    N Engl J Med. 2018;378:101-103.
    PubMed     Text format    
    
    
    December 2017
38. IMPRIALOS KP, Stavropoulos K, Doumas M
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    PubMed     Text format    
    
    
    
39. HOLMAN RR, Bethel MA, Hernandez AF
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    PubMed     Text format    
    
    
    
40. TSIARAS SV, Safi LM, Ghoshhajra BB, Lindsay ME, et al
    Case 39-2017. A 41-Year-Old Woman with Recurrent Chest Pain.
    N Engl J Med. 2017;377:2475-2484.
    PubMed     Text format    
    
    
    
41. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:2267-2272.
    PubMed     Text format    
    
    
    November 2017
42. 
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-2099.
    PubMed     Text format    
    
    
    
43. RAJAGOPALAN S, Brook R
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098-9.
    PubMed     Text format    
    
    
    
44. FERNANDEZBALSELLS MM, Sojo-Vega L, Ricart-Engel W
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098.
    PubMed     Text format    
    
    
    
45. BAGLIONI P
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-8.
    PubMed     Text format    
    
    
    
46. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:e29.
    PubMed     Text format    
    
    
    
47. MAZER CD, Whitlock RP, Fergusson DA, Hall J, et al
    Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
    N Engl J Med. 2017 Nov 12. doi: 10.1056/NEJMoa1711818.
    PubMed     Text format     Abstract available
    
    
    
48. JACOB KA, Gianoli M, van Dijk D
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897-8.
    PubMed     Text format    
    
    
    
49. TAGGART DP, Puskas JD
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897.
    PubMed     Text format    
    
    
    
50. JONES SG, Pullan MD, Kirmani BH
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1896-7.
    PubMed     Text format    
    
    
    
51. NOZAWA T, Imagawa T, Ito S
    Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki's Disease.
    N Engl J Med. 2017;377:1894-1896.
    PubMed     Text format    
    
    
    
52. 
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1898-1899.
    PubMed     Text format    
    
    
    October 2017
53. THIELE H, Akin I, Sandri M, Fuernau G, et al
    PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.
    N Engl J Med. 2017 Oct 30. doi: 10.1056/NEJMoa1710261.
    PubMed     Text format     Abstract available
    
    
    
54. MONTONE RA, Minelli S
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595-6.
    PubMed     Text format    
    
    
    
55. AGGARWAL S, Pavlides G
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595.
    PubMed     Text format    
    
    
    
56. BHATT DL
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1598-1599.
    PubMed     Text format    
    
    
    
57. DAVIES JE, Sen S, Escaned J
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1597-1598.
    PubMed     Text format    
    
    
    
58. PIJLS NHJ, De Bruyne B
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596.
    PubMed     Text format    
    
    
    
59. 
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596-7.
    PubMed     Text format    
    
    
    September 2017
60. BOWMAN L, Hopewell JC, Chen F, Wallendszus K, et al
    Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
    N Engl J Med. 2017;377:1217-1227.
    PubMed     Text format     Abstract available
    
    
    
61. RIDKER PM, Everett BM, Thuren T, MacFadyen JG, et al
    Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    N Engl J Med. 2017;377:1119-1131.
    PubMed     Text format     Abstract available
    
    
    
62. HOLMAN RR, Bethel MA, Mentz RJ, Thompson VP, et al
    Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017 Sep 14. doi: 10.1056/NEJMoa1612917.
    PubMed     Text format     Abstract available
    
    
    August 2017
63. HOFMANN R, James SK, Jernberg T, Lindahl B, et al
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2017 Aug 28. doi: 10.1056/NEJMoa1706222.
    PubMed     Text format     Abstract available
    
    
    
64. LOSCALZO J
    Is Oxygen Therapy Beneficial in Acute Myocardial Infarction? Simple Question, Complicated Mechanism, Simple Answer.
    N Engl J Med. 2017 Aug 28. doi: 10.1056/NEJMe1709250.
    PubMed     Text format    
    
    
    
65. ERLINGE D, Omerovic E, Frobert O, Linder R, et al
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2017 Aug 27. doi: 10.1056/NEJMoa1706443.
    PubMed     Text format     Abstract available
    
    
    
66. STONE GW
    Procedural Anticoagulation in Myocardial Infarction.
    N Engl J Med. 2017 Aug 27. doi: 10.1056/NEJMe1709247.
    PubMed     Text format    
    
    
    
67. EIKELBOOM JW, Connolly SJ, Bosch J, Dagenais GR, et al
    Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
    N Engl J Med. 2017 Aug 27. doi: 10.1056/NEJMoa1709118.
    PubMed     Text format     Abstract available
    
    
    
68. HARRINGTON RA
    Targeting Inflammation in Coronary Artery Disease.
    N Engl J Med. 2017 Aug 27. doi: 10.1056/NEJMe1709904.
    PubMed     Text format    
    
    
    
69. REDBERG RF, Prasad V
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:786-7.
    PubMed     Text format    
    
    
    
70. NACI H, Mehra MR
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:785-6.
    PubMed     Text format    
    
    
    
71. GARCIA DE TENA J, Morales-Ortega A, Pindao-Quesada G
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:785.
    PubMed     Text format    
    
    
    
72. NUNES JPL
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:787.
    PubMed     Text format    
    
    
    
73. KOSKINAS KC, Windecker S
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:786.
    PubMed     Text format    
    
    
    
74. SABATINE MS, Giugliano RP, Pedersen TR
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:787-8.
    PubMed     Text format    
    
    
    
75. SHROYER AL, Hattler B, Wagner TH, Collins JF, et al
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:623-632.
    PubMed     Text format     Abstract available
    
    
    July 2017
76. BIBAS L, Thanassoulis G
    Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017;377:396-7.
    PubMed     Text format    
    
    
    
77. FERRANTE G, Stefanini GG
    Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017;377:397.
    PubMed     Text format    
    
    
    
78. 
    Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017;377:397-8.
    PubMed     Text format    
    
    
    
79. MARTINEZ-CERON E, Garcia-Rio F
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;377:300.
    PubMed     Text format    
    
    
    
80. 
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;377:300-301.
    PubMed     Text format    
    
    
    
81. CHRISTEN T, de Mutsert R
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;377:95.
    PubMed     Text format    
    
    
    
82. 
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;377:94-96.
    PubMed     Text format    
    
    
    
83. XU L, Li D
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;377:94.
    PubMed     Text format    
    
    
    
84. MIHAS C, Kantzanou M
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;377:94.
    PubMed     Text format    
    
    
    
85. JANI SM, Nallamothu BK, Cooper LT, Smith A, et al
    Beating, Fast and Slow.
    N Engl J Med. 2017;377:72-78.
    PubMed     Text format    
    
    
    June 2017
86. KONDO T, Terada K
    Coronary-Artery Vasospasm.
    N Engl J Med. 2017;376:e52.
    PubMed     Text format    
    
    
    
87. JAISWAL S, Natarajan P, Silver AJ, Gibson CJ, et al
    Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
    N Engl J Med. 2017 Jun 21. doi: 10.1056/NEJMoa1701719.
    PubMed     Text format     Abstract available
    
    
    
88. WYKRZYKOWSKA JJ, Kraak RP, Hofma SH, van der Schaaf RJ, et al
    Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.
    N Engl J Med. 2017;376:2319-2328.
    PubMed     Text format     Abstract available
    
    
    
89. NEAL B, Perkovic V, Mahaffey KW, de Zeeuw D, et al
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017 Jun 12. doi: 10.1056/NEJMoa1611925.
    PubMed     Text format     Abstract available
    
    
    May 2017
90. ANDERSON JL, Morrow DA
    Acute Myocardial Infarction.
    N Engl J Med. 2017;376:2053-2064.
    PubMed     Text format    
    
    
    
91. DEWEY FE, Gusarova V, Dunbar RL, O'Dushlaine C, et al
    Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.
    N Engl J Med. 2017 May 24. doi: 10.1056/NEJMoa1612790.
    PubMed     Text format     Abstract available
    
    
    
92. GRAHAM MJ, Lee RG, Brandt TA, Tai LJ, et al
    Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides.
    N Engl J Med. 2017 May 24. doi: 10.1056/NEJMoa1701329.
    PubMed     Text format     Abstract available
    
    
    
93. LINCOFF AM, Nicholls SJ, Riesmeyer JS, Barter PJ, et al
    Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
    N Engl J Med. 2017;376:1933-1942.
    PubMed     Text format     Abstract available
    
    
    
94. BHATT DL
    Assessment of Stable Coronary Lesions.
    N Engl J Med. 2017;376:1879-1881.
    PubMed     Text format    
    
    
    
95. WANG DSH, Mazer CD, Orser BA
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1891-2.
    PubMed     Text format    
    
    
    
96. JIMENEZ-RIVERA JJ, Iribarren-Sarrias JL, Martinez-Sanz R
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1891.
    PubMed     Text format    
    
    
    
97. MYLES PS, Smith JA, Painter T
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1893.
    PubMed     Text format    
    
    
    
98. MILOJEVIC M, Kappetein AP, Head SJ
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1892.
    PubMed     Text format    
    
    
    
99. DAWES TJ, Price S
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1892-3.
    PubMed     Text format    
    
    
    
100. DAVIES JE, Sen S, Dehbi HM, Al-Lamee R, et al
     Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI.
     N Engl J Med. 2017;376:1824-1834.
     PubMed     Text format     Abstract available
     
     
     
101. GOTBERG M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, et al
     Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI.
     N Engl J Med. 2017;376:1813-1823.
     PubMed     Text format     Abstract available
     
     
     April 2017
102. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
     Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
     N Engl J Med. 2017;376:1407-1418.
     PubMed     Text format     Abstract available
     
     
     
103. JENA AB, Mann NC, Wedlund LN, Olenski A, et al
     Delays in Emergency Care and Mortality during Major U.S. Marathons.
     N Engl J Med. 2017;376:1441-1450.
     PubMed     Text format     Abstract available
     
     
     
104. PACKER M, O'Connor C, McMurray JJ, Wittes J, et al
     Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure.
     N Engl J Med. 2017 Apr 12. doi: 10.1056/NEJMoa1601895.
     PubMed     Text format     Abstract available
     
     
     
105. BANGALORE S, Fayyad R, Laskey R, DeMicco DA, et al
     Body-Weight Fluctuations and Outcomes in Coronary Disease.
     N Engl J Med. 2017;376:1332-1340.
     PubMed     Text format     Abstract available
     
     
     
106. KERALIYA A, Blankstein R
     Regression of Coronary Atherosclerosis with Medical Therapy.
     N Engl J Med. 2017;376:1370.
     PubMed     Text format    
     
     
     
107. NISSEN SE
     Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
     N Engl J Med. 2017;376:1390.
     PubMed     Text format    
     
     
     
108. GROSSER T
     Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
     N Engl J Med. 2017;376:1389.
     PubMed     Text format    
     
     
     March 2017
109. DEFILIPPIS EM, Vaidya A, Ramani S, French C, et al
     Under Pressure.
     N Engl J Med. 2017;376:e23.
     PubMed     Text format    
     
     
     
110. KULLO IJ, Fan X, Ding K
     Genetic Risk, Lifestyle, and Coronary Artery Disease.
     N Engl J Med. 2017;376:1192-3.
     PubMed     Text format    
     
     
     
111. ELLISON DH
     Genetic Risk, Lifestyle, and Coronary Artery Disease.
     N Engl J Med. 2017;376:1194.
     PubMed     Text format    
     
     
     
112. RAPPAPORT SM, Neophytou AM
     Genetic Risk, Lifestyle, and Coronary Artery Disease.
     N Engl J Med. 2017;376:1193.
     PubMed     Text format    
     
     
     
113. 
     Genetic Risk, Lifestyle, and Coronary Artery Disease.
     N Engl J Med. 2017;376:1194-5.
     PubMed     Text format    
     
     
     
114. MEHTA RH, Leimberger JD, van Diepen S, Meza J, et al
     Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
     N Engl J Med. 2017 Mar 19. doi: 10.1056/NEJMoa1616218.
     PubMed     Text format     Abstract available
     
     
     
115. KOBER L
     Complete Revascularization in ST-Elevation Myocardial Infarction?
     N Engl J Med. 2017 Mar 18. doi: 10.1056/NEJMe1702825.
     PubMed     Text format    
     
     
     
116. SMITS PC, Abdel-Wahab M, Neumann FJ, Boxma-de Klerk BM, et al
     Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
     N Engl J Med. 2017 Mar 18. doi: 10.1056/NEJMoa1701067.
     PubMed     Text format     Abstract available
     
     
     
117. RAY KK, Landmesser U, Leiter LA, Kallend D, et al
     Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.
     N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615758.
     PubMed     Text format     Abstract available
     
     
     
118. RIDKER PM, Revkin J, Amarenco P, Brunell R, et al
     Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
     N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1701488.
     PubMed     Text format     Abstract available
     
     
     
119. DULLAART RP
     PCSK9 Inhibition to Reduce Cardiovascular Events.
     N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMe1703138.
     PubMed     Text format    
     
     
     
120. SABATINE MS, Giugliano RP, Keech AC, Honarpour N, et al
     Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
     N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615664.
     PubMed     Text format     Abstract available
     
     
     
121. BELLEYCOTE EP, Lamy AR, Whitlock RP
     Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
     N Engl J Med. 2017;376:1087-8.
     PubMed     Text format    
     
     
     
122. CHRISTIANSEN EH, Makikallio T, Holm NR
     Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
     N Engl J Med. 2017;376:1088-9.
     PubMed     Text format    
     
     
     
123. 
     Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
     N Engl J Med. 2017;376:1089.
     PubMed     Text format    
     
     
     
124. LIKOSKY DS, Baker RA
     Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
     N Engl J Med. 2017;376:894.
     PubMed     Text format    
     
     
     
125. IPP E, Genter P, Childress K
     Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
     N Engl J Med. 2017;376:890-1.
     PubMed     Text format    
     
     
     
126. 
     Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
     N Engl J Med. 2017;379:890-1.
     PubMed     Text format    
     
     
     
127. COSMI F, Laini R, Nicolucci A
     Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
     N Engl J Med. 2017;376:890.
     PubMed     Text format    
     
     
     
128. 
     Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
     N Engl J Med. 2017;376:894-895.
     PubMed     Text format    
     
     
     
129. WILLIAMS TC, Stewart E
     Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
     N Engl J Med. 2017;376:891.
     PubMed     Text format    
     
     
     
130. 
     Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
     N Engl J Med. 2017;376:891-2.
     PubMed     Text format    
     
     
     December 2016
131. FARSHID A
     Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
     N Engl J Med. 2016;375:2604.
     PubMed     Text format    
     
     
     
132. URBAN P, Oldroyd K, Krackhardt F
     Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
     N Engl J Med. 2016;375:2603-2604.
     PubMed     Text format    
     
     
     
133. 
     Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
     N Engl J Med. 2016;375:2602-2605.
     PubMed     Text format    
     
     
     
134. BANGALORE S
     Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
     N Engl J Med. 2016;375:2602-3.
     PubMed     Text format    
     
     
     
135. VORA AN, Rao SV, Stone GW
     Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
     N Engl J Med. 2016;375:2602.
     PubMed     Text format    
     
     
     
136. TAGGART DP, Altman DG, Gray AM, Lees B, et al
     Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts.
     N Engl J Med. 2016;375:2540-9.
     PubMed     Text format     Abstract available
     
     
     
137. BATES ER
     Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
     N Engl J Med. 2016;375:2605.
     PubMed     Text format    
     
     
     
138. KHERA AV, Emdin CA, Drake I, Natarajan P, et al
     Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease.
     N Engl J Med. 2016;375:2349-2358.
     PubMed     Text format     Abstract available
     
     
     
139. O'DONNELL M, Mann JF, Schutte AE, Staessen JA, et al
     Dietary Sodium and Cardiovascular Disease Risk.
     N Engl J Med. 2016;375:2404-2408.
     PubMed     Text format    
     
     
     
140. 
     Dietary Sodium and Cardiovascular Disease Risk.
     N Engl J Med. 2016;375:2404-2408.
     PubMed     Text format    
     
     
     
141. JOHNS DM
     Dietary Sodium and Cardiovascular Disease Risk.
     N Engl J Med. 2016;375:2407.
     PubMed     Text format    
     
     
     
142. GRAUDAL N
     Dietary Sodium and Cardiovascular Disease Risk.
     N Engl J Med. 2016;375:2405-6.
     PubMed     Text format    
     
     
     
143. ALDERMAN MH
     Dietary Sodium and Cardiovascular Disease Risk.
     N Engl J Med. 2016;375:2405.
     PubMed     Text format    
     
     
     
144. SNIDERMAN AD, Thanassoulis G
     Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
     N Engl J Med. 2016;375:2304.
     PubMed     Text format    
     
     
     
145. MORRISON AC, Fu YP, O'Donnell CJ
     Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
     N Engl J Med. 2016;375:2303.
     PubMed     Text format    
     
     
     
146. 
     Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
     N Engl J Med. 2016;375:2303-2306.
     PubMed     Text format    
     
     
     
147. STITZIEL NO
     Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
     N Engl J Med. 2016;375:2306.
     PubMed     Text format    
     
     
     
148. MORIERI ML, Shah H, Doria A
     Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
     N Engl J Med. 2016;375:2304-2305.
     PubMed     Text format    
     
     
     
149. HEGELE RA
     Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
     N Engl J Med. 2016;375:2303-2304.
     PubMed     Text format    
     
     
     
150. CONTOU D, de Prost N
     Skin Mottling.
     N Engl J Med. 2016;375:2187.
     PubMed     Text format    
     
     
     November 2016
151. CORREIA LC, Latado A, Porzsolt F
     Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2016;375:1798.
     PubMed     Text format    
     
     
     
152. COHEN S, Beckey C
     Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2016;375:1797.
     PubMed     Text format    
     
     
     
153. 
     Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2016;375:1797-1799.
     PubMed     Text format    
     
     
     
154. ALVAREZ-VILLALOBOS NA, Trevino-Alvarez AM, Gonzalez-Gonzalez JG
     Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2016;375:1797-8.
     PubMed     Text format    
     
     
     October 2016
155. BRAUNWALD E
     Treatment of Left Main Coronary Artery Disease.
     N Engl J Med. 2016.
     PubMed     Text format    
     
     
     
156. STONE GW, Sabik JF, Serruys PW, Simonton CA, et al
     Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
     N Engl J Med. 2016.
     PubMed     Text format     Abstract available
     
     
     
157. MYLES PS, Smith JA, Forbes A, Silbert B, et al
     Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
     N Engl J Med. 2016.
     PubMed     Text format     Abstract available
     
     
     
158. LAMY A, Devereaux PJ, Prabhakaran D, Taggart DP, et al
     Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
     N Engl J Med. 2016.
     PubMed     Text format     Abstract available
     
     
     
159. MOSLEHI JJ
     Cardiovascular Toxic Effects of Targeted Cancer Therapies.
     N Engl J Med. 2016;375:1457-1467.
     PubMed     Text format    
     
     
     
160. BUCHOLZ EM, Butala NM, Ma S, Normand ST, et al
     Life Expectancy after Myocardial Infarction, According to Hospital Performance.
     N Engl J Med. 2016;375:1332-1342.
     PubMed     Text format     Abstract available
     
     
     September 2016
161. DWYER T, Sinaiko AR, Raitakari OT
     Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
     N Engl J Med. 2016;375:1299-301.
     PubMed     Text format    
     
     
     
162. SHARMA A, Lavie C
     Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
     N Engl J Med. 2016;375:1299-301.
     PubMed     Text format    
     
     
     
163. 
     Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
     N Engl J Med. 2016;375:1299-301.
     PubMed     Text format    
     
     
     
164. MARSO SP, Bain SC, Consoli A, Eliaschewitz FG, et al
     Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
     N Engl J Med. 2016.
     PubMed     Text format     Abstract available
     
     
     
165. RAZA S, Blackstone EH, Sabik JF 3rd
     Coronary-Artery Bypass Grafting.
     N Engl J Med. 2016;375:e22.
     PubMed     Text format    
     
     
     
166. BARBATO E, Toth GG, De Bruyne B
     Coronary-Artery Bypass Grafting.
     N Engl J Med. 2016;375:e22.
     PubMed     Text format    
     
     
     
167. 
     Coronary-Artery Bypass Grafting.
     N Engl J Med. 2016;375:e22.
     PubMed     Text format    
     
     
     
168. GIANNONI A, Emdin M, Passino C
     Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea.
     N Engl J Med. 2016;375:1004-6.
     PubMed     Text format    
     
     
     August 2016
169. BATES ER
     Balancing the Evidence Base on Coronary Stents.
     N Engl J Med. 2016.
     PubMed     Text format    
     
     
     
170. BONAA KH, Mannsverk J, Wiseth R, Aaberge L, et al
     Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
     N Engl J Med. 2016.
     PubMed     Text format     Abstract available
     
     
     
171. MOKHLESI B, Ayas NT
     Cardiovascular Events in Obstructive Sleep Apnea - Can CPAP Therapy SAVE Lives?
     N Engl J Med. 2016.
     PubMed     Text format    
     
     
     
172. MCEVOY RD, Antic NA, Heeley E, Luo Y, et al
     CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea.
     N Engl J Med. 2016.
     PubMed     Text format     Abstract available
     
     
     
173. HU K, Xu W, Williams Z
     Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
     N Engl J Med. 2016;375:703-4.
     PubMed     Text format    
     
     
     
174. DOEHNER W, Anker SD
     Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
     N Engl J Med. 2016;375:703.
     PubMed     Text format    
     
     
     
175. BURSZTYN M
     Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
     N Engl J Med. 2016;375:702-3.
     PubMed     Text format    
     
     
     
176. VISCOLI CM, Kernan WN, Young LH
     Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
     N Engl J Med. 2016;375:704.
     PubMed     Text format    
     
     
     
177. BROTT TG, Voeks JH, Howard VJ
     Stenting versus Surgery for Carotid Stenosis.
     N Engl J Med. 2016;375:604-5.
     PubMed     Text format    
     
     
     
178. HUSSAIN MA, Al-Omran M
     Stenting versus Surgery for Carotid Stenosis.
     N Engl J Med. 2016;375:603.
     PubMed     Text format    
     
     
     
179. PARASKEVAS KI
     Stenting versus Surgery for Carotid Stenosis.
     N Engl J Med. 2016;375:602.
     PubMed     Text format    
     
     
     
180. SAMANTA A, Afzal MR
     Stenting versus Surgery for Carotid Stenosis.
     N Engl J Med. 2016;375:601-2.
     PubMed     Text format    
     
     
     
181. MATSUMURA J, Monteleone P, Rosenfield K
     Stenting versus Surgery for Carotid Stenosis.
     N Engl J Med. 2016;375:603-4.
     PubMed     Text format    
     
     
     
182. CHEN GC, Qin LQ
     Fruit Consumption and Cardiovascular Disease in China.
     N Engl J Med. 2016;375:488.
     PubMed     Text format    
     
     
     
183. KOPEL E
     Fruit Consumption and Cardiovascular Disease in China.
     N Engl J Med. 2016;375:488.
     PubMed     Text format    
     
     
     
184. LEOW MK
     Fruit Consumption and Cardiovascular Disease in China.
     N Engl J Med. 2016;375:487-8.
     PubMed     Text format    
     
     
     
185. DU H, Li L, Chen Z
     Fruit Consumption and Cardiovascular Disease in China.
     N Engl J Med. 2016;375:489.
     PubMed     Text format    
     
     
     
186. 
     Sharing Data from Cardiovascular Clinical Trials--A Proposal.
     N Engl J Med. 2016;375:407-9.
     PubMed     Text format    
     
     
     July 2016
187. 
     Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.
     N Engl J Med. 2016;375:398.
     PubMed     Text format     Abstract available
     
     
     
188. BASSAN M
     Chronic Stable Angina.
     N Engl J Med. 2016;375:292-3.
     PubMed     Text format    
     
     
     
189. WANITSCHEK MM, Dorler J, Alber HF
     Chronic Stable Angina.
     N Engl J Med. 2016;375:292.
     PubMed     Text format    
     
     
     
190. OHMAN EM
     Chronic Stable Angina.
     N Engl J Med. 2016;375:293.
     PubMed     Text format    
     
     
     
191. LI WW, Wollersheim LW, Morshuis WJ
     Aspirin before Coronary Artery Surgery.
     N Engl J Med. 2016;375:91.
     PubMed     Text format    
     
     
     
192. ALKHODAIR A, Cairns J
     Aspirin before Coronary Artery Surgery.
     N Engl J Med. 2016;375:90-1.
     PubMed     Text format    
     
     
     
193. MYLES PS, Smith JA, Painter T
     Aspirin before Coronary Artery Surgery.
     N Engl J Med. 2016;375:91-2.
     PubMed     Text format    
     
     
     June 2016
194. MARSO SP, Daniels GH, Brown-Frandsen K, Kristensen P, et al
     Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2016.
     PubMed     Text format     Abstract available
     
     
     
195. RADEMAKERS LM, Van Nunen LX
     IMAGES IN CLINICAL MEDICINE. Ventricular Septal Defect after Acute Myocardial Infarction.
     N Engl J Med. 2016;374:e28.
     PubMed     Text format    
     
     
     
196. COGSWELL ME, Mugavero K, Bowman BA, Frieden TR, et al
     Dietary Sodium and Cardiovascular Disease Risk - Measurement Matters.
     N Engl J Med. 2016.
     PubMed     Text format     Abstract available
     
     
     May 2016
197. ALEXANDER JH, Smith PK
     Coronary-Artery Bypass Grafting.
     N Engl J Med. 2016;374:1954-64.
     PubMed     Text format    
     
     
     
198. NIOI P, Sigurdsson A, Thorleifsson G, Helgason H, et al
     Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease.
     N Engl J Med. 2016.
     PubMed     Text format     Abstract available
     
     
     
199. TYBJAERG-HANSEN A
     The Sialylation Pathway and Coronary Artery Disease.
     N Engl J Med. 2016.
     PubMed     Text format     Abstract available
     
     
     
200. 
     Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
     N Engl J Med. 2016;374:1898.
     PubMed     Text format    
     
     
     
201. SAPP JL, Wells GA, Parkash R, Stevenson WG, et al
     Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
     N Engl J Med. 2016.
     PubMed     Text format     Abstract available
     
     
     April 2016
202. MICHLER RE, Smith PK, Parides MK, Ailawadi G, et al
     Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.
     N Engl J Med. 2016.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: